Guardian Pharmacy Services, Inc. GRDN
41.21
(0.58)
(1.39%)
as of 25 Sep
- Market cap
- $2.7B
- P/E
- 39.2×
Follow GRDN
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 30.14% | 26.83% | 26.76% | 24.43% |
+7 more TTM periods Free account |
|
| 16.48% | 13.95% | 13.42% | 10.90% | ||
ROIC |
31.82% | 28.86% | 29.83% | 23.07% | |
Return on Tangible Assets |
41.94% | 40.43% | 42.27% | 43.53% | |
Average Days of Receivables |
25.88 | 28.00 | 25.60 | 27.89 | |
Free Cash Flow per Share |
1.26 | 1.11 | 1.29 | 1.10 | |
Free Cash Flow |
79.79 | 70.28 | 80.71 | 68.17 | |
Capital Expenditures |
(19.07) | (18.49) | (19.54) | (19.82) | |
Piotroski F-Score |
6.00 | 6.00 | 6.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
28.45% | 29.86% | 35.36% | 37.93% | |
Accounts Receivable Turnover |
14.79 | 13.93 | 14.58 | 14.10 | |
Accounts Payable Turnover |
10.76 | 10.95 | 10.57 | 9.76 | |
Inventory Turnover |
24.25 | 25.42 | 27.55 | 23.97 | |
Average Days of Payables |
34.44 | 34.41 | 36.69 | 39.82 | |
Days of Inventory on Hand |
16.05 | 14.95 | 13.69 | 15.66 | |
Tax Rate |
(0.31) | (0.32) | (0.33) | (0.32) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.79% | 15.61% | 15.19% | 15.52% | |
Share Based Compensation of Revenue |
0.70% | 0.81% | 0.96% | 1.17% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.50 | 1.67 | 2.04 | 2.19 | |
Depreciation/Fixed assets |
0.41 | 0.41 | 0.40 | 0.39 | |
Capex/Depreciation |
(0.82) | (0.80) | (0.88) | (0.91) | |
Revenue per Share |
23.11 | 22.99 | 23.22 | 22.37 | |
Operating CF per Share |
1.56 | 1.40 | 1.61 | 1.42 | |
Capex per Share |
(0.30) | (0.29) | (0.31) | (0.32) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
4.50% | 3.64% | 3.40% | 2.90% |
Columns are period end dates